topotecan has been researched along with Acute Kidney Failure in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cassier, P; Chapet, O; Chekrine, T; De Bari, B; Kulisa, M; Mornex, F | 1 |
| Mullangi, R; Mustafa, S; Pasha, K; Srinivas, NR; Venkatesh, P | 1 |
1 review(s) available for topotecan and Acute Kidney Failure
| Article | Year |
|---|---|
[Small cell neuroendocrine carcinoma of the bladder: A case report and review of the literature].
Topics: Acute Kidney Injury; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Carcinoma in Situ; Carcinoma, Neuroendocrine; Carcinoma, Transitional Cell; Combined Modality Therapy; Emergencies; Etoposide; Humans; Lymphatic Irradiation; Lymphatic Metastasis; Male; Neoadjuvant Therapy; Neoplasms, Multiple Primary; Prognosis; Prostatic Hyperplasia; Topoisomerase I Inhibitors; Topotecan; Urinary Bladder Neoplasms | 2011 |
1 other study(ies) available for topotecan and Acute Kidney Failure
| Article | Year |
|---|---|
Altered intravenous pharmacokinetics of topotecan in rats with acute renal failure (ARF) induced by uranyl nitrate: do adenosine A1 antagonists (selective/non-selective) normalize the altered topotecan kinetics in ARF?
Topics: Acute Kidney Injury; Adenosine A1 Receptor Antagonists; Animals; Caffeine; Drug Interactions; In Vitro Techniques; Injections, Intravenous; Kidney; Male; Microsomes, Liver; Rats; Rats, Wistar; Topotecan; Uranyl Nitrate; Xanthines; Xenobiotics | 2006 |